한국어
English
日本語
中文(简体)
Dainol Tablet (Ethylenediamine Disodium Phosphate)
200mg
Tablet · Prescription medication
Chodang Pharmaceutical Industry Co., Ltd.
Etidronate disodium is a bone resorption inhibitor used in the treatment of osteoporosis.
MFDS ingredient code M260477
Etidronate disodium is a non-steroidal bone resorption inhibitor used in the treatment of skeletal disorders. It helps to maintain bone density by reducing calcium loss from bones. It is primarily used in the treatment of metabolic bone diseases such as osteoporosis.
This ingredient inhibits the activity of osteoclasts, the cells that break down bone, thereby reducing calcium loss from bones. As a result, it prevents bones from becoming weak and increases bone density, lowering the risk of fractures.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other bisphosphonate class drugs, etidronate disodium can also affect bone formation. Additionally, there is a potential risk of inhibiting bone formation with long-term use, making the regulation of duration and dosage important.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.